There have been 7 recent insider transactions recorded for PhaseBio Pharmaceuticals, Inc. (PHASQ), including 2 buys and 5 sells.
Notable insiders with recent activity include Harrigan Edmund, Loewy Caroline M, Hutson Nancy J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — PHASQ
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2023-05-19 |
Harrigan Edmund |
Director |
Option Exercise |
3,750 |
- |
- |
- |
| 2023-05-19 |
Loewy Caroline M |
Director |
Option Exercise (Sell) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Hutson Nancy J |
Director |
Option Exercise (Sell) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Van Den Broek Richard |
Director |
Option Exercise (Sell) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Thorp Clay |
Director |
Option Exercise |
3,750 |
- |
- |
- |
| 2023-05-19 |
Humphries William D. |
Director |
Option Exercise (Sell) |
2,538 |
- |
- |
- |
| 2023-05-19 |
Sapir Alex |
Director |
Option Exercise (Sell) |
3,750 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
